Spectrochim Acta A Mol Biomol Spectrosc
March 2025
Photo-responsive switches are very promising materials due to their potential applications in many fields. However, photo-controlled color/fluorescence dual-switching with higher modulation efficiency has rarely been reported. Herein, two new optical responsive switches were constructed by Eu-doped ZnO@Silane quantum dots (Eu:ZnO@Silane QDs) and two diarylethenes.
View Article and Find Full Text PDFPhotochem Photobiol Sci
October 2023
Carbon dots (CDs) as luminescent zero-dimensional carbon nanomaterials have good aqueous dissolution, photostability, high quantum yield, and tunability of emission color. It has great application potential in many fields, including bioimaging, labeling of biological species, drug delivery, and sensing in biomedical. However, controlling the fluorescence emission of carbon dots remains a formidable challenge.
View Article and Find Full Text PDFDeveloping fluorescence switching as functional system is highly desirable for potential applications in the fields of light-responsive materials or devices. Attempt to construct fluorescence switching system tend to focus on the high fluorescence modulation efficiency, especially in solid state. Herein, a photo-controlled fluorescence switching system was constructed with photochromic diarylethene and trimethoxysilane modified zinc oxide quantum dots (Si-ZnO QDs) successfully.
View Article and Find Full Text PDFObjective: To explore the function of Tangnaikang (TNK) in the prevention and treatment of renal interstitial fibrosis through transdifferentiation of the human renal tubular epithelial cell line HK-2 induced by transforming growth factor-beta1 (TGF-beta1).
Methods: HK-2 cells cultured in dulbecco's modified eagle medium/F12 (1 : 1) with 10% fetal calf serum were divided into six groups: blank control group, TGF-beta1 group (TGF-beta1 10 ng/mL), serum control group (TGF-beta1 10 ng/mL + 10% serum), treatment group 1 (TGF-beta1 10 ng/mL + 5% TNK serum), treatment group 2 (TGF-beta1 10 ng/mL + 10% TNK serum), and treatment group 3 (TGF-beta1 10 ng/mL + 20% TNK serum). Cell proliferation was detected by 4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.